{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-002890","form_type":"8-K","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.667250+00:00","generated_at":"2026-06-15T22:06:19.388482+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Joint Corp Q1 revenue up 27% to $28.5M; net income $2.3M includes $3.9M ERC credits","bullets":["Revenue $28.5M (+27% YoY); system-wide sales $115.4M (+17%); system-wide comp sales +8%.","Operating loss $678K vs loss $176K YoY; net income $2.3M ($0.15 diluted) vs net loss $206K, includes $3.9M ERC.","Adjusted EBITDA $2.0M vs $1.8M; clinic count 870 (740 franchised, 130 co-owned), up 32 from Dec 2022.","2023 guidance reaffirmed: revenue $123-128M, Adj. EBITDA $12.5-14.0M, franchised openings 100-120, co-owned greenfield 8-12.","Opened greenfield clinic at Fort Dix in April; fourth with Army & Air Force Exchange Service."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-002890","json":"https://secwatch.observer/filing/0001171843-23-002890.json","markdown":"https://secwatch.observer/filing/0001171843-23-002890.md","text":"https://secwatch.observer/filing/0001171843-23-002890.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323002890/0001171843-23-002890-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323002890/f8k_050423.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T22:06:19.388482+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e7673b139ec816ecfdd7d14d6821b8d08ecbe647","claim":"JOINT Corp reported the quarter ended March 31, 2023 results: revenue $28.5 million, net income $2.3 million, EPS $0.15 per diluted share. Guidance reaffirmed.","evidence_excerpt":"franchisor of chiropractic clinics, reported its financial results for the quarter ended March 31, 2023. Financial Highlights: Q1 2023 Compared to Q1 2022 Grew revenue 27% to $28.5 million. Reported operating loss of $678,000, compared to a loss of $176,000. Reported net income of $2.3 million, including $3.9 million of employee retention credits, compared to a net","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184323002890/0001171843-23-002890-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2023"},{"label":"Revenue","value":"$28.5 million"},{"label":"Net income","value":"$2.3 million"},{"label":"EPS","value":"$0.15 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}